Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.49 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | TACR2 | P21452 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SHBG | P04278 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2252177 | 1.00 | ACLY (0.49) | ACLYKAT8PPARAESR1ADRA2A | |
| SCHEMBL2243900 | 1.00 | ACLY (0.49) | ACLYKAT8PPARAESR1ADRA2A | |
| SCHEMBL2246598 | 1.00 | ACLY (0.49) | ACLYKAT8PPARAESR1ADRA2A | |
| SCHEMBL2250134 | 1.00 | ACLY (0.49) | ACLYKAT8PPARAESR1ADRA2A | |
| SCHEMBL8526269 | 0.83 | PPARA (0.57) | KAT8PPARAESR1ADRA2AADORA3 | |
| SCHEMBL11960981 | 0.83 | KAT8 (0.47) | KAT8PPARAESR1ADRA2AADORA3 | |
| SCHEMBL11597077 | 0.83 | KAT8 (0.47) | ACLYKAT8PPARAESR1ADRA2A | |
| SCHEMBL27848142 | 0.83 | KAT8 (0.47) | ACLYKAT8PPARAESR1ADRA2A | |
| SCHEMBL8526381 | 0.83 | PPARA (0.57) | KAT8PPARAESR1ADRA2AADORA3 | |
| SCHEMBL8525773 | 0.83 | PPARA (0.57) | KAT8PPARAESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9145360-B2 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | FUJI XEROX CO., LTD. (JP) | 2015-09-29 | — | — | US | claimed |
| US-9145360-B2 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | FUJI XEROX CO., LTD. (JP) | 2015-09-29 | — | — | US | disclosed |
| US-8637632-B2 | Method for producing binder resin, particulate resin dispersion and method for producing same, electrostatic image development toner and method for producing same, electrostatic image developer, and image forming method | FUJI XEROX CO., LTD. (JP) | 2014-01-28 | — | — | US | disclosed |
| US-20110269066-A1 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | FUJI XEROX CO., LTD. (JP) | 2011-11-03 | — | — | US | disclosed |
| US-8003821-B2 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | FUJI XEROX CO., LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| US-20070287088-A1 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | FUJI XEROX CO., LTD. (JP) | 2007-12-13 | — | — | US | disclosed |
| US-20070122730-A1 | Method for producing binder resin, particulate resin dispersion and method for producing same, electrostatic image development toner and method for producing same, electrostatic image developer, and image forming method | FUJI XEROX CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287088-A1 | Bronsted acid compound, manufacturing method of condensation compound, dispersion liquid of condensation compound particles, manufacturing method of electrostatic image developing toner, manufacturing method of binder resin, binder resin, dispersion liquid of resin particles, electrostatic image developing toner, electrostatic image developer, and image-forming method | RCC1, BET1, BRI3BP | ACLY 3220/4885KAT8 981/4885PPARA 1896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.